Tüberküloz İmmünopatogenezi

Authors

Haluk Barbaros Oral

References

Gong W, Wu X. Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy. Frontiers in Microbiology. 2021 Oct 22;12. doi:10.3389/fmicb.2021.745592

Philips JA, Ernst JD. Tuberculosis pathogenesis and immunity. Annual Reviews of Pathology. 2012;7:353–84. doi:10.1146/annurev-pathol-011811-132458 PubMed PMID: 22054143.

Ryndak MB, Laal S. Mycobacterium tuberculosis Primary Infection and Dissemination: A Critical Role for Alveolar Epithelial Cells. Frontiers in Cellular and Infection Microbiology. 2019 Aug 21;9. doi:10.3389/fcimb.2019.00299

Ryndak MB, Singh KK, Peng Z, Laal S. Transcriptional profiling of Mycobacterium tuberculosis replicating in the human type II alveolar epithelial cell line, A549. Genom Data. 2015 Sep;5:112–4. doi:10.1016/j.gdata.2015.05.026

Mvubu NE, Pillay B, Gamieldien J, Bishai W, Pillay M. Canonical pathways, networks and transcriptional factor regulation by clinical strains of Mycobacterium tuberculosis in pulmonary alveolar epithelial cells. Tuberculosis. 2016 Mar;97:73–85. doi:10.1016/j.tube.2015.12.002

Mvubu NE, Pillay B, McKinnon LR, Pillay M. Mycobacterium tuberculosis strains induce strain-specific cytokine and chemokine response in pulmonary epithelial cells. Cytokine. 2018 Apr;104:53–64. doi:10.1016/j.cyto.2017.09.027

de Waal AM, Hiemstra PS, Ottenhoff TH, Joosten SA, van der Does AM. Lung epithelial cells interact with immune cells and bacteria to shape the microenvironment in tuberculosis. Thorax. 2022 Apr;77(4):408–16. doi:10.1136/thoraxjnl-2021-217997

Mvubu NE. Innate immune recognition of Mycobacterium tuberculosis: receptor engagement and inflammatory outcomes at the site of infection. The Cell Surface. 2025 Dec;14:100150. doi:10.1016/j.tcsw.2025.100150

Kleinnijenhuis J, Oosting M, Joosten LAB, Netea MG, Van Crevel R. Innate Immune Recognition of Mycobacterium tuberculosis. Clinical and Developmental Immunology. 2011;2011:1–12. doi:10.1155/2011/405310

Zihad SMNK, Sifat N, Islam MA, Monjur-Al-Hossain ASM, Sikdar KMYK, Sarker MMR, et al. Role of pattern recognition receptors in sensing Mycobacterium tuberculosis. Heliyon. 2023 Oct;9(10):e20636. doi:10.1016/j.heliyon.2023.e20636

Briken V, Porcelli SA, Besra GS, Kremer L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Molecular Microbiology. 2004 Jul 16;53(2):391–403. doi:10.1111/j.1365-2958.2004.04183.x

Ishikawa E, Ishikawa T, Morita YS, Toyonaga K, Yamada H, Takeuchi O, et al. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. Journal of Experimental Medicine. 2009 Dec 21;206(13):2879–88. doi:10.1084/jem.20091750

Schoenen H, Bodendorfer B, Hitchens K, Manzanero S, Werninghaus K, Nimmerjahn F, et al. Cutting Edge: Mincle Is Essential for Recognition and Adjuvanticity of the Mycobacterial Cord Factor and its Synthetic Analog Trehalose-Dibehenate. The Journal of Immunology. 2010 Mar 15;184(6):2756–60. doi:10.4049/jimmunol.0904013

Torigoe S, Salie S, Keeton R, Aylan B, Appelmelk BJ, Williams DL, et al. Mycobacterial α-glucans hijack dectin-1 to facilitate intracellular bacterial survival. Science Immunology. 2026 Jan 9;11(115). doi:10.1126/sciimmunol.adw0732

Kang PB, Azad AK, Torrelles JB, Kaufman TM, Beharka A, Tibesar E, et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. Journal of Experimental Medicine. 2005 Oct 3;202(7):987–99. doi:10.1084/jem.20051239

Liu CH, Liu H, Ge B. Innate immunity in tuberculosis: host defense vs pathogen evasion. Cellular and Molecular Immunology. 2017 Dec 11;14(12):963–75. doi:10.1038/cmi.2017.88

Kolonko M, Geffken AC, Blumer T, Hagens K, Schaible UE, Hagedorn M. WASH-driven actin polymerization is required for efficient mycobacterial phagosome maturation arrest. Cellular Microbiology. 2014 Feb;16(2):232–46. doi:10.1111/cmi.12217

Bussi C, Gutierrez MG. Mycobacterium tuberculosis infection of host cells in space and time. FEMS Microbiology Reviews. 2019 Jul 1;43(4):341–61. doi:10.1093/femsre/fuz006

Weiss G, Schaible UE. Macrophage defense mechanisms against intracellular bacteria. Immunological Reviews. 2015 Mar 20;264(1):182–203. doi:10.1111/imr.12266

Schneider BE, Behrends J, Hagens K, Harmel N, Shayman JA, Schaible UE. Lysosomal phospholipase A 2 : A novel player in host immunity to Mycobacterium tuberculosis. European Journal of Immunology. 2014 Aug 11;44(8):2394–404. doi:10.1002/eji.201344383

Zhuang L, Yang L, Li L, Ye Z, Gong W. Mycobacterium tuberculosis : immune response, biomarkers, and therapeutic intervention. MedComm (Beijing). 2024 Jan 6;5(1). doi:10.1002/mco2.419

Clay H, Volkman HE, Ramakrishnan L. Tumor Necrosis Factor Signaling Mediates Resistance to Mycobacteria by Inhibiting Bacterial Growth and Macrophage Death. Immunity. 2008 Aug;29(2):283–94. doi:10.1016/j.immuni.2008.06.011

Roca FJ, Whitworth LJ, Redmond S, Jones AA, Ramakrishnan L. TNF Induces Pathogenic Programmed Macrophage Necrosis in Tuberculosis through a Mitochondrial-Lysosomal-Endoplasmic Reticulum Circuit. Cell. 2019 Sep;178(6):1344-1361.e11. doi:10.1016/j.cell.2019.08.004

Bekker LG, Moreira AL, Bergtold A, Freeman S, Ryffel B, Kaplan G. Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infection and Immunity. 2000;68(12):6954–61. PubMed PMID: 11083819.

Bourigault M, Segueni N, Rose S, Court N, Vacher R, Vasseur V, et al. Relative contribution of IL‐1α, IL‐1β and TNF to the host response to Mycobacterium tuberculosis and attenuated M. bovis BCG. Immunity, Inflammation and Disease. 2013 Oct 30;1(1):47–62. doi:10.1002/iid3.9

van der Wel N, Hava D, Houben D, Fluitsma D, van Zon M, Pierson J, et al. M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells. Cell. 2007 Jun;129(7):1287–98. doi:10.1016/j.cell.2007.05.059

Oral B. Tüberküloz İmmünopatogenezi. In: Yüce A, Özyurt M, Sürücüoğlu S, Uzun M, Sarıgüzel N, editors. Mycobacterium tuberkulosis ve Tüberküloz. İstanbul: ANKA Matbaacılık; 2016. p. 112–27.

Chandra P, Grigsby SJ, Philips JA. Immune evasion and provocation by Mycobacterium tuberculosis. Nature Reviews Microbiology. 2022 Dec 25;20(12):750–66. doi:10.1038/s41579-022-00763-4

Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. Journal of Experimental Medicine. 1992 Apr 1;175(4):1111–22. doi:10.1084/jem.175.4.1111

MacMicking JD, Taylor GA, McKinney JD. Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47. Science (1979). 2003 Oct 24;302(5645):654–9. doi:10.1126/science.1088063

Singh SB, Davis AS, Taylor GA, Deretic V. Human IRGM Induces Autophagy to Eliminate Intracellular Mycobacteria. Science (1979). 2006 Sep 8;313(5792):1438–41. doi:10.1126/science.1129577

Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, et al. Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages. Journal of Experimental Medicine. 2003 Sep 1;198(5):693–704. doi:10.1084/jem.20030846

DHEDA K, SCHWANDER SK, ZHU B, Van ZYL‐SMIT RN, ZHANG Y. The immunology of tuberculosis: From bench to bedside. Respirology. 2010 Apr 29;15(3):433–50. doi:10.1111/j.1440-1843.2010.01739.x

Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response. Science (1979). 2006 Mar 24;311(5768):1770–3. doi:10.1126/science.1123933

Martineau AR, Wilkinson KA, Newton SM, Floto RA, Norman AW, Skolimowska K, et al. IFN-γ- and TNF-Independent Vitamin D-Inducible Human Suppression of Mycobacteria: The Role of Cathelicidin LL-37. The Journal of Immunology. 2007 Jun 1;178(11):7190–8. doi:10.4049/jimmunol.178.11.7190

Liu PT, Stenger S, Tang DH, Modlin RL. Cutting Edge: Vitamin D-Mediated Human Antimicrobial Activity against Mycobacterium tuberculosis Is Dependent on the Induction of Cathelicidin. The Journal of Immunology. 2007 Aug 15;179(4):2060–3. doi:10.4049/jimmunol.179.4.2060

Kim JH, Park JS, Cho YJ, Yoon HI, Song JH, Lee CT, et al. Low serum 25-hydroxyvitamin D level: An independent risk factor for tuberculosis? Clinical Nutrition. 2014 Dec;33(6):1081–6. doi:10.1016/j.clnu.2013.11.014

Cong J, Wei H. Natural Killer Cells in the Lungs. Frontiers in Immunology. 2019 Jun 25;10. doi:10.3389/fimmu.2019.01416

Abebe F. Immunological basis of early clearance of Mycobacterium tuberculosis infection: the role of natural killer cells. Clincal and Experimental Immunology. 2021 Mar 10;204(1):32–40. doi:10.1111/cei.13565

Chu J, Gao F, Yan M, Zhao S, Yan Z, Shi B, et al. Natural killer cells: a promising immunotherapy for cancer. Jornal of Translational Medicine. 2022 May 23;20(1):240. doi:10.1186/s12967-022-03437-0

Esin S, Counoupas C, Aulicino A, Brancatisano FL, Maisetta G, Bottai D, et al. Interaction of Mycobacterium tuberculosis Cell Wall Components with the Human Natural Killer Cell Receptors NK p44 and Toll‐Like Receptor 2. Scandanivian Joırnal of Immunology. 2013 Jun 22;77(6):460–9. doi:10.1111/sji.12052

Vankayalapati R, Garg A, Porgador A, Griffith DE, Klucar P, Safi H, et al. Role of NK Cell-Activating Receptors and Their Ligands in the Lysis of Mononuclear Phagocytes Infected with an Intracellular Bacterium. The Journal of Immunology. 2005 Oct 1;175(7):4611–7. doi:10.4049/jimmunol.175.7.4611

Dhiman R, Indramohan M, Barnes PF, Nayak RC, Paidipally P, Rao LVM, et al. IL-22 Produced by Human NK Cells Inhibits Growth of Mycobacterium tuberculosis by Enhancing Phagolysosomal Fusion. The Journal of Immunology. 2009 Nov 15;183(10):6639–45. doi:10.4049/jimmunol.0902587

Schierloh P, Alemán M, Yokobori N, Alves L, Roldán N, Abbate E, et al. NK cell activity in tuberculosis is associated with impaired CD11a and ICAM‐1 expression: a regulatory role of monocytes in NK activation. Immunology. 2005 Dec 7;116(4):541–52. doi:10.1111/j.1365-2567.2005.02259.x

Paidipally P, Tripathi D, Van A, Radhakrishnan RK, Dhiman R, Venkatasubramanian S, et al. Interleukin-21 Regulates Natural Killer Cell Responses During Mycobacterium tuberculosis Infection. Journal of Infectious Diseases. 2018 Mar 28;217(8):1323–33. doi:10.1093/infdis/jiy034

Choreño Parra JA, Martínez Zúñiga N, Jiménez Zamudio LA, Jiménez Álvarez LA, Salinas Lara C, Zúñiga J. Memory of Natural Killer Cells: A New Chance against Mycobacterium tuberculosis? Frontiers in Immunology. 2017 Aug 14;8. doi:10.3389/fimmu.2017.00967

Sankar P, Mishra BB. Early innate cell interactions with Mycobacterium tuberculosis in protection and pathology of tuberculosis. Frontiers in Immunology. 2023 Oct 27;14. doi:10.3389/fimmu.2023.1260859

Feng CG, Kaviratne M, Rothfuchs AG, Cheever A, Hieny S, Young HA, et al. NK Cell-Derived IFN-γ Differentially Regulates Innate Resistance and Neutrophil Response in T Cell-Deficient Hosts Infected with Mycobacterium tuberculosis. The Journal of Immunology. 2006 Nov 15;177(10):7086–93. doi:10.4049/jimmunol.177.10.7086

Su R, Peng Y ping, Deng Z, Deng Y ting, Ye J qing, Guo Y, et al. Mycobacterium tuberculosis Infection Induces Low-Density Granulocyte Generation by Promoting Neutrophil Extracellular Trap Formation via ROS Pathway. Frontiers in Microbiology. 2019 Jul 11;10. doi:10.3389/fmicb.2019.01468

Butov DО, Kuzhko MM, Kalmykovа IМ, Kuznetsova IМ, Butova TS, Grinishina OО, et al. Changes in nitric oxide synthase and nitrite and nitrate serum levels in patients with or without MDR-TB undergoing the intensive phase of anti-tuberculosis therapy. The International Journal of Mycobacteriology. 2014 Jun;3(2):139–43. doi:10.1016/j.ijmyco.2014.02.003

Jones GS, Amirault HJ, Andersen BR. Killing of Mycobacterium tuberculosis by Neutrophils: A Nonoxidative Process. Journal of Infectious Diseases. 1990 Sep;162(3):700–4. doi:10.1093/infdis/162.3.700

Alcantara CA, Glassman I, Nguyen KH, Parthasarathy A, Venketaraman V. Neutrophils in Mycobacterium tuberculosis. Vaccines (Basel). 2023 Mar 12;11(3):631. doi:10.3390/vaccines11030631

Warren E, Teskey G, Venketaraman V. Effector Mechanisms of Neutrophils within the Innate Immune System in Response to Mycobacterium tuberculosis Infection. Journal of Clinical Medicine. 2017 Feb 7;6(2):15. doi:10.3390/jcm6020015

Flynn JL, Chan J. Immune cell interactions in tuberculosis. Cell. 2022 Dec;185(25):4682–702. doi:10.1016/j.cell.2022.10.025

Blomgran R, Ernst JD. Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection. The Journal of Immunology. 2011;186(12):7110–9. doi:10.4049/jimmunol.1100001 PubMed PMID: 21555529.

Eruslanov EB, Lyadova I V., Kondratieva TK, Majorov KB, Scheglov I V., Orlova MO, et al. Neutrophil Responses to Mycobacterium tuberculosis Infection in Genetically Susceptible and Resistant Mice. Infection and Immunity. 2005 Mar;73(3):1744–53. doi:10.1128/IAI.73.3.1744-1753.2005

Keller C, Hoffmann R, Lang R, Brandau S, Hermann C, Ehlers S. Genetically Determined Susceptibility to Tuberculosis in Mice Causally Involves Accelerated and Enhanced Recruitment of Granulocytes. Infection and Immunity. 2006 Jul;74(7):4295–309. doi:10.1128/IAI.00057-06

Kimmey JM, Huynh JP, Weiss LA, Park S, Kambal A, Debnath J, et al. Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection. Nature. 2015 Dec 9;528(7583):565–9. doi:10.1038/nature16451

Stutz MD, Allison CC, Ojaimi S, Preston SP, Doerflinger M, Arandjelovic P, et al. Macrophage and neutrophil death programs differentially confer resistance to tuberculosis. Immunity. 2021 Aug;54(8):1758-1771.e7. doi:10.1016/j.immuni.2021.06.009

Collin M, Bigley V. Human dendritic cell subsets: an update. Immunology. 2018 May 27;154(1):3–20. doi:10.1111/imm.12888

Xin H ming, Peng Y zhi, Yuan Z qiang, Guo H. In vitro maturation and migration of immature dendritic cells after chemokine receptor 7 transfection. Canadian Journal Microbiology. 2009 Jul;55(7):859–66. doi:10.1139/W09-041

Ehlers S. DC-SIGN and mannosylated surface structures of Mycobacterium tuberculosis: a deceptive liaison. European Journal of Cell Biology. 2010 Jan;89(1):95–101. doi:10.1016/j.ejcb.2009.10.004

Liu J, Zhang X, Chen K, Cheng Y, Liu S, Xia M, et al. CCR7 Chemokine Receptor-Inducible lnc-Dpf3 Restrains Dendritic Cell Migration by Inhibiting HIF-1α-Mediated Glycolysis. Immunity. 2019 Mar;50(3):600-615.e15. doi:10.1016/j.immuni.2019.01.021

Fucikova J, Palova-Jelinkova L, Bartunkova J, Spisek R. Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications. Frontiers in Immunology. 2019 Oct 29;10. doi:10.3389/fimmu.2019.02393

Ye Z, Chen Z, Sami A, El-Gayed A, Xiang J. Human Dendritic Cells Engineered to Express Alpha Tumor Necrosis Factor Maintain Cellular Maturation and T-Cell Stimulation Capacity. Cancer Biotherapy and Radiopharmaceuticals. 2006 Dec;21(6):613–22. doi:10.1089/cbr.2006.21.613

Dustin ML. T‐cell activation through immunological synapses and kinapses. Immunological Reviews. 2008 Feb 7;221(1):77–89. doi:10.1111/j.1600-065X.2008.00589.x

Allison JP. CD28-B7 interactions in T-cell activation. Current Opinion in Immunology. 1994 Jun;6(3):414–9. doi:10.1016/0952-7915(94)90120-1

Kapina MA, Shepelkova GS, Mischenko V V, Sayles P, Bogacheva P, Winslow G, et al. CD27low CD4 T Lymphocytes That Accumulate in the Mouse Lungs during Mycobacterial Infection Differentiate from CD27high Precursors In Situ, Produce IFN-γ, and Protect the Host against Tuberculosis Infection. The Journal of Immunology. 2007 Jan 15;178(2):976–85. doi:10.4049/jimmunol.178.2.976

Schluger NW. Recent advances in our understanding of human host responses to tuberculosis. Respiratory Research. 2001 Mar 29;2(3):157. doi:10.1186/rr53

Ouyang W, Kolls JK, Zheng Y. The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation. Immunity. 2008 Apr;28(4):454–67. doi:10.1016/j.immuni.2008.03.004

Cooper AM. T cells in mycobacterial infection and disease. Current Opinion in Immunology. 2009 Aug;21(4):378–84. doi:10.1016/j.coi.2009.06.004

Jenkins MR, Griffiths GM. The synapse and cytolytic machinery of cytotoxic T cells. Current Opinion in Immunology. 2010 Jun;22(3):308–13. doi:10.1016/j.coi.2010.02.008

Lord SJ, Rajotte R V., Korbutt GS, Bleackley RC. Granzyme B: a natural born killer. Immunological Reviews. 2003 Jun 12;193(1):31–8. doi:10.1034/j.1600-065X.2003.00044.x

Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. Journal of Experimental Medicine. 1983 Sep 1;158(3):670–89. doi:10.1084/jem.158.3.670

Abebe F, Belay M, Legesse M, K. L. M. C. F, Ottenhoff THM. IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals. PLoS One. 2018 Jan 26;13(1):e0190989. doi:10.1371/journal.pone.0190989

Krause R, Ogongo P, Tezera L, Ahmed M, Mbano I, Chambers M, et al. B cell heterogeneity in human tuberculosis highlights compartment-specific phenotype and functional roles. Communications Biology. 2024 May 16;7(1):584. doi:10.1038/s42003-024-06282-7

Bénard A, Sakwa I, Schierloh P, Colom A, Mercier I, Tailleux L, et al. B Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 2018 Mar 15;197(6):801–13. doi:10.1164/rccm.201707-1475OC

Lu LL, Chung AW, Rosebrock TR, Ghebremichael M, Yu WH, Grace PS, et al. A Functional Role for Antibodies in Tuberculosis. Cell. 2016 Oct;167(2):433-443.e14. doi:10.1016/j.cell.2016.08.072

Grace PS, Peters JM, Sixsmith J, Lu R, Irvine EB, Luedeman C, et al. Antibody-Fab and -Fc features promote Mycobacterium tuberculosis restriction. Immunity. 2025 Jun;58(6):1586-1597.e5. doi:10.1016/j.immuni.2025.05.004

Irvine EB, Nikolov A, Khan MZ, Peters JM, Lu R, Sixsmith J, et al. Fc-engineered antibodies promote neutrophil-dependent control of Mycobacterium tuberculosis. Nature Microbiology. 2024 Aug 22;9(9):2369–82. doi:10.1038/s41564-024-01777-9

Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, Bardou F, et al. Foamy Macrophages from Tuberculous Patients’ Granulomas Constitute a Nutrient-Rich Reservoir for M. tuberculosis Persistence. PLoS Pathogens. 2008 Nov 11;4(11):e1000204. doi:10.1371/journal.ppat.1000204

Chang JC, Miner MD, Pandey AK, Gill WP, Harik NS, Sassetti CM, et al. igr Genes and Mycobacterium tuberculosis Cholesterol Metabolism. Journal of Bacteriology. 2009 Aug 15;191(16):5232–9. doi:10.1128/JB.00452-09

Griffin JE, Pandey AK, Gilmore SA, Mizrahi V, Mckinney JD, Bertozzi CR, et al. Cholesterol Catabolism by Mycobacterium tuberculosis Requires Transcriptional and Metabolic Adaptations. Cell Chemical Biology. 2012 Feb;19(2):218–27. doi:10.1016/j.chembiol.2011.12.016

Puissegur MP, Lay G, Gilleron M, Botella L, Nigou J, Marrakchi H, et al. Mycobacterial Lipomannan Induces Granuloma Macrophage Fusion via a TLR2-Dependent, ADAM9- and β1 Integrin-Mediated Pathway. The Journal of Immunology. 2007 Mar 1;178(5):3161–9. doi:10.4049/jimmunol.178.5.3161

Lay G, Poquet Y, Salek‐Peyron P, Puissegur M, Botanch C, Bon H, et al. Langhans giant cells from M. tuberculosis ‐induced human granulomas cannot mediate mycobacterial uptake. Journal of Pathology. 2007 Jan 17;211(1):76–85. doi:10.1002/path.2092

Wolf AJ, Desvignes L, Linas B, Banaiee N, Tamura T, Takatsu K, et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. Journal of Experimental Medicine. 2008 Jan 21;205(1):105–15. doi:10.1084/jem.20071367

Randhawa PS. Lymphocyte subsets in granulomas of human tuberculosis: An in situ immunofluorescence study using monoclonal antibodies. Pathology. 1990;22(3):153–5. doi:10.3109/00313029009063555

Egen JG, Rothfuchs AG, Feng CG, Winter N, Sher A, Germain RN. Macrophage and T Cell Dynamics during the Development and Disintegration of Mycobacterial Granulomas. Immunity. 2008 Feb;28(2):271–84. doi:10.1016/j.immuni.2007.12.010

Maglione PJ, Xu J, Chan J. B Cells Moderate Inflammatory Progression and Enhance Bacterial Containment upon Pulmonary Challenge with Mycobacterium tuberculosis. The Journal of Immunology. 2007 Jun 1;178(11):7222–34. doi:10.4049/jimmunol.178.11.7222

Flynn JL, Chan J, Lin PL. Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunology. 2011;4(3):271–8. doi:10.1038/mi.2011.14 PubMed PMID: 21430653.

Lin PL, Rodgers M, Smith L, Bigbee M, Myers A, Bigbee C, et al. Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model. Infection and Immunity. 2009 Oct;77(10):4631–42. doi:10.1128/IAI.00592-09

Ulrichs T, Kaufmann SH. New insights into the function of granulomas in human tuberculosis. Journal of Pathology. 2006 Jan 17;208(2):261–9. doi:10.1002/path.1906

Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F. Foamy macrophages and the progression of the human tuberculosis granuloma. Nature Immunology. 2009 Sep 19;10(9):943–8. doi:10.1038/ni.1781

Eum SY, Kong JH, Hong MS, Lee YJ, Kim JH, Hwang SH, et al. Neutrophils Are the Predominant Infected Phagocytic Cells in the Airways of Patients With Active Pulmonary TB. Chest. 2010 Jan;137(1):122–8. doi:10.1378/chest.09-0903

Published

November 17, 2026

License

License